Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Brainomix, the AI-powered medtech company, announces the publication of a new study in the prestigious peer-reviewed journal American Journal of...
Brainomix, the AI-powered medtech solutions company, has heralded its continued US expansion with the launch of its full suite of FDA-cleared modules ...
Brainomix Ltd, an AI-powered medtech solutions company, and Nanoflex Robotics AG, a remote robotic surgical company based in Switzerland, have been...
Brainomix, the AI-powered medtech solutions company, today announced it has moved to a new head office in Oxford, located in the landmark Seacourt...
Brainomix has been announced as the newest member of the CEO Roundtable on Cancer, a non-profit organization founded in 2001 following the vision of...
Brainomix, the AI-powered medtech solutions company, today announced that its Brainomix 360 e-ASPECTS tool for stroke has received FDA clearance,...
Brainomix has announced its involvement in a new study sponsored by the University of Liverpool focused on post-stroke atrial fibrillation (AF)....
Brainomix, an AI-powered medtech solutions company, has announced a new partnership with Pixyl, an award-winning, Grenoble-based medtech specializing ...
Brainomix, the AI-powered medtech solutions company, and Bridge Biotherapeutics, Inc., a South Korean clinical-stage biotechnology company focused on ...
Brainomix, the AI-powered medtech solutions company, today announces that it has been awarded the national tender in Hungary to deploy its AI stroke...
Brainomix, the AI-powered medtech solutions company, today announces that it has closed a series B financing round, raising £16M ($21.2M) to fund its ...
Each year more than 100,000 people will suffer a stroke in Poland, with some patients requiring specialist treatment in the form of mechanical...
Brainomix, an Oxford-based company specializing in the creation of AI-powered imaging biomarkers to enable precision medicine for better treatment...
Brainomix has announced the launch of its new e-Stroke Suite 9.0. Building on a legacy of continual innovation, this latest version incorporates...
October 29th marks World Stroke Day, a day focused on raising awareness of stroke and its symptoms. Each year, nearly 14 million people worldwide...
A new study published this week in the International Journal of Stroke (IJS) showed that Brainomix's e-ASPECTS software can reliably tell doctors how ...
e-CTA®, developed by Brainomix, provides fast, consistent collateral assessments powered by AI and Deep Learning, based on CTA analysis. The recently ...
The e-Stroke Suite revolutionizes the traditional imaging for stroke diagnosis by using Artificial Intelligence (AI) and Deep Learning algorithms to...
- Study suggests that it may be reasonable to select patients for thrombectomy in centres without access to advanced imaging using the e-ASPECTS tool ...
The Angels Initiative, a unique healthcare initiative launched by Boehringer Ingelheim in partnership with the European Stroke Organisation (ESO),...
Brainomix, an Oxford-based world leader in medical imaging software, is teaming up with the University of Oxford to become one of its technology...
e-CTA proporciona evaluaciones colaterales automatizadas rápidas que utilizan IA y big data y que están basadas en el análisis CTA Brainomix, una...
e-CTA fournit des évaluations des collatérales rapides et automatisées, optimisées par l'intelligence artificielle et le Big Data, basées sur...
e-CTA bietet mithilfe von KI und Big Data schnelle, automatisierte Kollateralbewertungen auf Basis von CTA-Analysen Brainomix, ein Unternehmen für...
Brainomix s'appuie sur un partenariat avec Boehringer Ingelheim pour le traitement rapide et assisté par l'intelligente artificielle des victimes...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.